2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole

C258H154N34O4 — CID 159566399

IUPAC2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole
SMILESc1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccc%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)cc1.c1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccn%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)nc1.c1ccc(-c2nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8nc(-c9ccccc9)c9ccccc9n8)c7c6)o5)cc43)nc3ccccc23)cc1.c1ccc2c(-c3ccc(-c4nc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10nc(-c%11ccc(-c%12cccc%13ccccc%12%13)cc%11)c%11ccccc%11n%10)c9c8)o7)cc65)nc5ccccc45)cc3)cccc2c1
InChIInChI=1S/C74H44N8O.C66H40N8O.C64H38N10O.C54H32N8O/c1-3-19-53-45(15-1)17-13-25-55(53)47-31-35-49(36-32-47)69-61-23-5-9-27-63(61)75-73(77-69)81-65-29-11-7-21-57(65)59-41-39-51(43-67(59)81)71-79-80-72(83-71)52-40-42-60-58-22-8-12-30-66(58)82(68(60)44-52)74-76-64-28-10-6-24-62(64)70(78-74)50-37-33-48(34-38-50)56-26-14-18-46-16-2-4-20-54(46)56;1-3-15-41(16-4-1)43-27-31-45(32-28-43)61-53-21-7-11-23-55(53)67-65(69-61)73-57-25-13-9-19-49(57)51-37-35-47(39-59(51)73)63-71-72-64(75-63)48-36-38-52-50-20-10-14-26-58(50)74(60(52)40-48)66-68-56-24-12-8-22-54(56)62(70-66)46-33-29-44(30-34-46)42-17-5-2-6-18-42;1-5-19-53-49(15-1)59(41-27-23-39(24-28-41)51-17-9-11-35-65-51)69-63(67-53)73-55-21-7-3-13-45(55)47-33-31-43(37-57(47)73)61-71-72-62(75-61)44-32-34-48-46-14-4-8-22-56(46)74(58(48)38-44)64-68-54-20-6-2-16-50(54)60(70-64)42-29-25-40(26-30-42)52-18-10-12-36-66-52;1-3-15-33(16-4-1)49-41-21-7-11-23-43(41)55-53(57-49)61-45-25-13-9-19-37(45)39-29-27-35(31-47(39)61)51-59-60-52(63-51)36-28-30-40-38-20-10-14-26-46(38)62(48(40)32-36)54-56-44-24-12-8-22-42(44)50(58-54)34-17-5-2-6-18-34/h1-44H;1-40H;1-38H;1-32H
InChIKeyMHGGBJOPZAZUFD-UHFFFAOYSA-N
MW3794.30 g/mol
LogP62.37
Rot. Bonds30

About 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole

2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole (PubChem CID 159566399) has the molecular formula C258H154N34O4 and a molecular weight of 3794.30 g/mol. Its IUPAC name is 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole
PubChem CID159566399
Molecular FormulaC258H154N34O4
Molecular Weight3794.30 g/mol
Exact Mass3791.29
IUPAC Name2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole
SMILESc1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccc%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)cc1.c1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccn%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)nc1.c1ccc(-c2nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8nc(-c9ccccc9)c9ccccc9n8)c7c6)o5)cc43)nc3ccccc23)cc1.c1ccc2c(-c3ccc(-c4nc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10nc(-c%11ccc(-c%12cccc%13ccccc%12%13)cc%11)c%11ccccc%11n%10)c9c8)o7)cc65)nc5ccccc45)cc3)cccc2c1
InChIInChI=1S/C74H44N8O.C66H40N8O.C64H38N10O.C54H32N8O/c1-3-19-53-45(15-1)17-13-25-55(53)47-31-35-49(36-32-47)69-61-23-5-9-27-63(61)75-73(77-69)81-65-29-11-7-21-57(65)59-41-39-51(43-67(59)81)71-79-80-72(83-71)52-40-42-60-58-22-8-12-30-66(58)82(68(60)44-52)74-76-64-28-10-6-24-62(64)70(78-74)50-37-33-48(34-38-50)56-26-14-18-46-16-2-4-20-54(46)56;1-3-15-41(16-4-1)43-27-31-45(32-28-43)61-53-21-7-11-23-55(53)67-65(69-61)73-57-25-13-9-19-49(57)51-37-35-47(39-59(51)73)63-71-72-64(75-63)48-36-38-52-50-20-10-14-26-58(50)74(60(52)40-48)66-68-56-24-12-8-22-54(56)62(70-66)46-33-29-44(30-34-46)42-17-5-2-6-18-42;1-5-19-53-49(15-1)59(41-27-23-39(24-28-41)51-17-9-11-35-65-51)69-63(67-53)73-55-21-7-3-13-45(55)47-33-31-43(37-57(47)73)61-71-72-62(75-61)44-32-34-48-46-14-4-8-22-56(46)74(58(48)38-44)64-68-54-20-6-2-16-50(54)60(70-64)42-29-25-40(26-30-42)52-18-10-12-36-66-52;1-3-15-33(16-4-1)49-41-21-7-11-23-43(41)55-53(57-49)61-45-25-13-9-19-37(45)39-29-27-35(31-47(39)61)51-59-60-52(63-51)36-28-30-40-38-20-10-14-26-46(38)62(48(40)32-36)54-56-44-24-12-8-22-42(44)50(58-54)34-17-5-2-6-18-34/h1-44H;1-40H;1-38H;1-32H
InChIKeyMHGGBJOPZAZUFD-UHFFFAOYSA-N
XLogP62.37
TPSA427.14 Ų
H-Bond Donors
H-Bond Acceptors38
Rotatable Bonds30
Heavy Atoms296
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003794.30
LogP ≤ 562.37
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1038

Analyze 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole?
The IUPAC name of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole (CID 159566399) is 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole.
What is the SMILES notation for 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole?
The canonical SMILES for 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole is c1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccc%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)cc1.c1ccc(-c2ccc(-c3nc(-n4c5ccccc5c5ccc(-c6nnc(-c7ccc8c9ccccc9n(-c9nc(-c%10ccc(-c%11ccccn%11)cc%10)c%10ccccc%10n9)c8c7)o6)cc54)nc4ccccc34)cc2)nc1.c1ccc(-c2nc(-n3c4ccccc4c4ccc(-c5nnc(-c6ccc7c8ccccc8n(-c8nc(-c9ccccc9)c9ccccc9n8)c7c6)o5)cc43)nc3ccccc23)cc1.c1ccc2c(-c3ccc(-c4nc(-n5c6ccccc6c6ccc(-c7nnc(-c8ccc9c%10ccccc%10n(-c%10nc(-c%11ccc(-c%12cccc%13ccccc%12%13)cc%11)c%11ccccc%11n%10)c9c8)o7)cc65)nc5ccccc45)cc3)cccc2c1.
What is the InChIKey of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole?
The InChIKey is MHGGBJOPZAZUFD-UHFFFAOYSA-N. The full InChI is InChI=1S/C74H44N8O.C66H40N8O.C64H38N10O.C54H32N8O/c1-3-19-53-45(15-1)17-13-25-55(53)47-31-35-49(36-32-47)69-61-23-5-9-27-63(61)75-73(77-69)81-65-29-11-7-21-57(65)59-41-39-51(43-67(59)81)71-79-80-72(83-71)52-40-42-60-58-22-8-12-30-66(58)82(68(60)44-52)74-76-64-28-10-6-24-62(64)70(78-74)50-37-33-48(34-38-50)56-26-14-18-46-16-2-4-20-54(46)56;1-3-15-41(16-4-1)43-27-31-45(32-28-43)61-53-21-7-11-23-55(53)67-65(69-61)73-57-25-13-9-19-49(57)51-37-35-47(39-59(51)73)63-71-72-64(75-63)48-36-38-52-50-20-10-14-26-58(50)74(60(52)40-48)66-68-56-24-12-8-22-54(56)62(70-66)46-33-29-44(30-34-46)42-17-5-2-6-18-42;1-5-19-53-49(15-1)59(41-27-23-39(24-28-41)51-17-9-11-35-65-51)69-63(67-53)73-55-21-7-3-13-45(55)47-33-31-43(37-57(47)73)61-71-72-62(75-61)44-32-34-48-46-14-4-8-22-56(46)74(58(48)38-44)64-68-54-20-6-2-16-50(54)60(70-64)42-29-25-40(26-30-42)52-18-10-12-36-66-52;1-3-15-33(16-4-1)49-41-21-7-11-23-43(41)55-53(57-49)61-45-25-13-9-19-37(45)39-29-27-35(31-47(39)61)51-59-60-52(63-51)36-28-30-40-38-20-10-14-26-46(38)62(48(40)32-36)54-56-44-24-12-8-22-42(44)50(58-54)34-17-5-2-6-18-34/h1-44H;1-40H;1-38H;1-32H.
What are the key properties of 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole?
2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole has a molecular weight of 3794.30 g/mol, XLogP of 62.37, 30 rotatable bonds, 0 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for 2,5-bis[9-[4-(4-naphthalen-1-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-phenylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-(4-phenylquinazolin-2-yl)carbazol-2-yl]-1,3,4-oxadiazole;2,5-bis[9-[4-(4-pyridin-2-ylphenyl)quinazolin-2-yl]carbazol-2-yl]-1,3,4-oxadiazole is sourced from PubChem (CID 159566399), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).